Bausch Health (BHC)
(Real Time Quote from BATS)
$8.84 USD
+0.16 (1.84%)
Updated Jun 28, 2022 02:51 PM ET
5-Strong Sell of 5 5
A Value C Growth F Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Bausch Health Cos Inc. has a PEG ratio of 0.19 compared to the Medical - Generic Drugs industry's PEG ratio of 0.60.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its growth rate over the past 12 months. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BHC 8.84 +0.16(1.84%)
Will BHC be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for BHC based on the 1-3 month trading system that nearly triples the S&P 500.
Zacks News for BHC
Bausch (BHC) Suspends IPO Plans for Solta Medical
Why Is Bausch (BHC) Down 11.2% Since Last Earnings Report?
BHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Implied Volatility Surging for Bausch (BHC) Stock Options
New Strong Sell Stocks for May 19th
Bausch (BHC) Q1 Earnings and Revenues Miss, Stock Down
Other News for BHC
Bausch Health Stock Soared By 20%: What To Do Now
Bausch Health call volume above normal and directionally bullish
Opening Day: Golden Sun Rises In Debut As Ivanhoe Electric Delays IPO
Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO
What You Missed On Wall Street This Morning